Screening of some Traditionally Used Plants for Their Hepatoprotective Effect by Saleh I. Alqasoumi & Maged S. Abdel-Kader
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
14 
Screening of some Traditionally Used  
Plants for Their Hepatoprotective Effect  
Saleh I. Alqasoumi1,2 and Maged S. Abdel-Kader1 
1Department of Pharmacognosy, College of Pharmacy, Salman Bin Abdulaziz University, 
2Department of Pharmacognosy, College of Pharmacy, King Saud University, 
 Kingdom of Saudi Arabia 
1. Introduction  
Liver is one of the largest organs in human body and the chief site for intense metabolism 
and excretion (Ram, 2001). It has a surprising role in the maintenance, performance and 
regulating homeostasis of the body. It is involved with almost all the biochemical pathways 
responsible for growth, fight against disease, nutrient supply, energy provision and 
reproduction (Ward & Daly, 1999). The major functions of the liver are carbohydrate, 
protein and fat metabolism, detoxification, blood coagulation, immunomodulation, 
secretion of bile and storage of vitamin.  
Two major types of reactions occur in the liver in the presence of exogenous substances. The 
first involve chemical modification of function groups by oxidation, reduction, 
hydroxylation, sulfonation and dealkylation. Various enzymes including mixed oxidases, 
cytochromes P-450, and the glutathione S-acyltransferases are involved in such biochemical 
transformations that usually lead to inactivation of drugs. This step is usually followed by 
conversion of the resulted metabolites into more water-soluble derivatives that are excreted 
in the bile or urine via coupling with glucuronate, sulfate, acetate, taurine or glycine 
moieties (Ram, 2001).  
Liver damage inflicted by hepatotoxic agents is of grave consequences (Subramoniam & 
Pushpangadan, 1999). Liver ailments represent a major global health problem 
(Baranisrinivasan et al., 2009). Liver cirrhosis is the ninth leading cause of death in the USA 
(Kim et al., 2002). Toxic chemicals, xenobiotics, alcohol consumption, malnutrition, anaemia, 
medications, autoimmune disorders (Marina, 2006), viral infections (hepatitis A, B, C, D, 
etc.) and microbial infections (Sharma & Ahuja, 1997) are harmful and cause damage to the 
hepatocytes. Hepatotoxic chemicals cause damage to the liver cells mainly by inducing lipid 
peroxidation and other oxidative events (Dianzani et al., 1991).  
In spite of the tremendous advances in modern medicine, no effective drugs are available, 
which stimulate liver functions and/or offers protection to the liver from damage or help to 
regenerate hepatic cells (Chatterjee, 2000). In the absence of reliable liver protective drugs in 
modern medicine, there exists a challenge for pharmaceutical scientists to explore the 
potential of hepatoprotective activity of plants based on traditional use (Witte et al., 1983). A 
large number of medicinal preparations are recommended for the treatment of liver 
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disorders (Chatterjee, 2000) and quite often claimed to offer significant relief. Study of many 
traditional plants used for liver problems led to the discovery of active compounds yet 
developed to successful drugs. Silymarin (Morazzoni & Bombardelli, 1995), schisandrin B 
(Cyong et al., 2000), phyllanthin, hypophyllanthin, picroside I and kutkoside (Ram, 2001) 
are examples of natural antihepatotoxic compounds derived from traditional herbs. About 
600 commercial preparations with claimed liver protecting activity are available all over the 
world. About 100 Indian medicinal plants belonging to 40 families are components of liver 
herbal formulation (Handa et al., 1986). The effectiveness of most of these plant products 
must be scientifically verified to identify new medicaments for the management of liver 
disorders. 
2. Silymarin, the standard antihepatotoxic drug 
Silymarin, the collective name for an extract from milk thistle, Silybum marianum (L.) 
Gaertneri, is a naturally occurring flavonolignan. Silymarin is a mixture of stereoisomers 
mainly silybin (also called silybinin, silibin or silibinin) representing 80%, w/w of silymarin. 
Other minor stereoisomers include isosilybin, dihydrosilybin, silydianin and silychristin 
(Wagner et al., 1968). Silymarin protects experimental animals against the hepatotoxin α-
amanitin (Hahn et al., 1968) and has a strong antioxidant property (Comoglio et al., 
1990). Other reported biological properties of silymarin include inhibition of LOX (Fiebrich 
& Koch, 1979a) and PG synthetase (Fiebrich & Koch, 1979b). For decades, silymarin has been 
used clinically in Europe for the treatment of alcoholic liver disease and as antihepatotoxic 
agent (Salmi & Sarna, 1982). Silymarin is well tolerated and largely free of adverse effects 
(Comoglio et al., 1990). Silymarin act as an antioxidant by scavenging preoxidant free 
radicals and by increasing the intracellular concentration of glutathione (GSH). It also 
exhibits a regulatory action of cellular membrane permeability and increase its stability 
against xenobiotics injury, increasing the synthesis of ribosomal RNA by stimulating DNA 
polymerase-I, exerting a steroid like regulatory action on DNA transcription and stimulation 
of protein synthesis and regeneration of liver cells (Dehmlow et al., 1996; Saller et al., 2007). 
Silymarin efficacy is not limited to the treatment of toxic and metabolic liver damage; it is 
also effective in acute, chronic hepatitis and in inhibiting fibrotic activity (Saller et al., 2007). 
It acts as inhibitor of the transformation of stellate hepatocytes into myofibroblasts, this 
process is responsible for the deposition of collagen fibres leading to cirrhosis (Fraschini et 
al., 2002). 
3. Induction of liver toxicity in experimental animals 
In order to study the hepatoprotective effect of plant extracts or pure isolates it is necessary 
to induce liver toxicity in experimental animal models. The reported protocols for induction 
of liver toxicity varying greatly in terms of the used liver toxin, doses, duration and route of 
administration. Below is a collection of the most common experimental procedures use by 
different groups.  
3.1 Carbon tetrachloride-induced liver toxicity 
Liver damage induced by carbon tetrachloride is the most commonly used model for the 
screening of hepatoprotective drugs (Slater, 1965). The rise in serum levels of Glutamic 
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Pyruvate Transaminase (SGPT), Glutamic Oxaloacetic Transaminase (SGOT) and cholesterol 
following carbon tetrachloride has been attributed to the damaged structural integrity of the 
liver cells. These components are cytoplasmic in location and released into circulation after 
cellular damages (Sallie et al., 1991). Carbon tetrachloride also plays a significant role in 
inducing triacylglyceral accumulation, depletion of GSH, depression of protein synthesis 
and loss of enzymes activity (Recknagel et al., 1989). Carbon tetrachloride induces 
hepatotoxicity in rats following its metabolic activation in the hepatocytes. Therefore, it 
selectively causes toxicity in the liver cells while maintaining semi-normal metabolic 
function. Carbon tetrachloride is metabolically activated by the cytochrome P-450 
dependent mixed oxidease in the endoplasmic reticulum to form trichloromethyl free 
radical (.CCl3) and .Cl3COO which combined with critical cellular macromolecules, cellular 
lipids and proteins in the presence of oxygen to induce lipid peroxidation (Snyder & 
Andrews, 1996). Some of the lipid peroxidation products are reactive aldehydes, e.g., 4-
hydroxynonenal, which can form adducts with proteins (Weber et al., 2003). These 
consequences lead to changes in the structures of the endoplasmic reticulum and other 
membranes hence to increase in plasma membrane permeability to Ca2+ resulting in a severe 
disturbances of calcium homeostasis and consequently necrotic cell death (Weber et al., 
2003). The loss of metabolic enzyme activation, reduction of protein synthesis and loss of 
glucose-6-phosphatase activation, all lead to liver injury (Recknagel & Glende, 1973; Azri et 
al.,1992). In addition to the intracellular events, Kupffer cell activation can contribute to liver 
injury (elSisi et al., 1993). Kupffer cells are resident macrophages of the liver which 
constitute approximately 80% of the fixed macrophages in the body (McCuskey, 2006). They 
may enhance liver injury by oxidant stress (elSisi et al., 1993) or TNF-_ generation, which 
may lead to apoptosis (Shi et al., 1998). In more than 70% of the reviewed published data 
liver toxicity were experimentally induced by Carbon tetrachloride. However, the 
experimental procedures were considerably different.  
3.1.1 Single dose carbon tetrachloride-induced liver toxicity 
Acute liver toxicity can be induced by a single dose of carbon tetrachloride. However, the 
route of administration and dose are different from one research group to another. 
Intraperitoneal injection seems to be the most commonly used method for carbon 
tetrachloride administration due to the ease of handling and rapid onset of action. Rats are 
usually a popular experimental animal model and the reported doses were 3 ml/kg 
(Jamshidzadeh et al., 2005), 2.5 ml/kg (Sen et al., 1993; Nishigaki et al., 1992), 2 ml/kg 
(Channabasavaraj et al., 2008), 1.5 ml/kg (Bhadauria et al., 2009), 1.25 ml/kg (Rafatullah et 
al., 2008) or 0.5 ml/kg (Rao et al., 1993). In most cases, carbon tetrachloride is diluted with 
oils (1:1). The large variation in doses may arise from weather the stated volumes 
represented the volume of pure carbon tetrachloride or the total volume of the mixture. If 
this is the case, the wide range of doses from 3- 0.5 ml will shrink to 1 ml (1.5- 0.5 ml). In 
case of using mice as the experimental animal model the reported carbon tetrachloride doses 
were much less (0.01, 0.016. 0.02 and 0.03 ml/kg) (Amat et al., 2010; Suzuki et al., 1990; Zhou 
et al., 2010; Wang et al., 2008).  
Induction of liver toxicity via oral routes was also reported. The used doses were 1ml/kg 
(Harish & Shivanandappa, 2006) 1.25 ml/Kg (Aktay et al., 2000) and 1.5 ml/kg (Gilani, & 
Janbaz, 1995). Subcutaneous route for administration of carbon tetrachloride was also used 
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and the reported doses were 0.3 ml/kg (Kumar et al., 2009), 1 ml/kg (Ahmed et al., 2001) or 
1.25 ml/kg (Mohamed et al., 2005). 
3.1.2 Multi doses carbon tetrachloride-induced liver toxicity 
The most popular multi-dose protocol for induction of liver toxicity is the subcutaneous 
administration of 2 ml of carbon tetrachloride/olive oil mixture (1:1) in days 2 and 3 of a five 
days long experiment (Zafar & Ali, 1998). In another protocol, carbon tetrachloride/olive oil 
(1:1) mixture was given daily via intraperitoneal injection in a 7 days long experiment. The 
doses were 0.5 ml (Maheswari & Rao, 2005), 0.8 ml (Özbek et al, 2004) or 1 ml/kg 
(Somasundaram et al., 2010). In 14 days experiment carbon tetrachloride/liquid paraffin 
mixture (1:1) was administered intraperitoneal every 72 hours (Christian et al., 2006). Chronic 
reversible cirrhosis were induced in rats by oral administration of mixture of 20% carbon 
tetrachloride in corn oil at 0.5mL/ kg body weight doses twice a week (Monday and 
Thursday) for 6 weeks (Hernandez-Munoz et al., 2001). Subcutaneous injection of 50% carbon 
tetrachloride in liquid paraffin (3 mL/kg) every other day for four weeks was also used to 
induce chronic liver toxicity (Chun-ching & Wei-Chih, 1995). 
3.2 Paracetamol-induced liver toxicity 
Paracetamol (acetaminophen) is a well-known antipyretic and analgesic agent. Therapeutic 
doses of paracetamol are safe, however, toxic doses can produce fatal hepatic necrosis in 
man, rats and mice (Mitchell et al., 1973). Paracetamol is eliminated mainly as sulfate and 
glucoronide (Eriksson et al., 1992) when administered in the regular therapeutic doses. Only 
5% of the dose is converted into N-acetyl-p-benzoquineimine (NAPQI). However, upon 
administration of toxic doses of paracetamol the sulfation and glucoronidation routes 
become saturated and hence, higher percentage of paracetamol molecules are oxidized to 
highly reactive NAPQI by cytochrome p-450 enzymes. Semiquinone radicals, obtained by 
one electron reduction of NAPQI, has an extremely short half-life and is rapidly conjugated 
with glutathione (GSH), a sulphydryl donor which results in the depletion of liver GSH pool 
(Remirez et al., 1995). Under conditions of excessive NAPQI formation or reduced of 
glutathione store, NAPQI covalently binds to vital proteins, the lipid bilayer of hepatocyte 
membranes and increases the lipid peroxidation. The result is hepatocellular death and 
centrilobular liver necrosis (McConnachie et al., 2007). Due to liver injury caused by 
paracetamol overdose, the transport function of the hepatocytes gets disturbed resulting in 
leakage of plasma membrane (Zimmerman & Seeff, 1970), thus causing an increase in serum 
enzyme levels. 
When rats are used as experimental animal model a single oral dose of 2 gm/kg 
paracetamol was used to induce liver damage (Chattopadhyay, 2003). The dose in case of 
using mice was 250 mg/kg (Sabir & Rocha, 2008). Intraperitoneal route of administration 
was also utilized. A doses of 750 mg/kg (Bhakta et al., 2001) or 835 mg/kg (Yen et al., 2007) 
were administered to produce liver intoxication in rats, while lower doses of 300 mg/kg 
(Yuan et al., 2010) were used for induction of liver damage in mice. 
3.3 D-Galactosamine-induced liver toxicity 
Exogenous administration of D-galactosamine (D-GalN) has been found to induce liver 
damage closely resembles human viral hepatitis (Decker & Keppler, 1972). A single injection 
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of D-GalN can decrease the uracil nucleotides in the liver and heart (Wills & Asha, 2006). D-
GalN markedly depletes hepatic UDP-glucuronic acid whereas extrahepatic UDP-
glucuronic is minimally affected. This suggests that D-GalN predominantly inhibits hepatic 
glucuronidation. It disrupts the synthesis of essential uridylate nucleotides resulting in 
organelle injury. Depletion of these nucleotides ultimately impairs the synthesis of protein 
and glycoprotein, leads to progressive damage of cellular membranes. These consequences 
lead to change in cellular membrane permeability which leads to enzyme leakage to the 
circulation (Keppler et al., 1970; Abdul-Hussain & Mehendale, 1991). In addition, increased 
production of reactive oxygen species (ROS) has been reported in primary culture of rat 
hepatocytes treated with D-GalN (Quintero et al., 2002). Oxygen-derived free radicals 
released from activated hepatic-macrophages are also one of the primary causes of D-GalN-
induced liver damage (Shiratori et al., 1988; Hu & Chen, 1992).  
Experimentally induced liver damage was achieved in rats by a single dose of D-GalN 400 
mg/kg (Ferenčiková et al., 2003; Kmieć et al., 2000) or 200 mg/kg (Decker & Keppler, 1974) 
via intrapretoneal injection. For induction of liver toxicity in mice a single dose of 15 mg D-
GalN in 0.3mL saline per 20 g by intraperitoneal injection (Wang et al., 2000) was used. The 
use of D-GalN as liver toxin with a very small concentration of lipopolysaccharide (LPS) (10 
g/kg) was also reported (Tiegs et al., 1989). 
3.4 Other methods for induction of hepatotoxicity 
These methods include the use of some drugs with known side effects target the liver upon 
prolonged use. Rifampicin (1 g/kg in rats) (Anusuya et al., 1010), menadione (60 mg/kg in 
mice) (Ip et al., 2004) and anti-tubercular drugs were applied for induction of experimental 
liver toxicity (Tandon et al., 2008). Ethanol induced liver damage is a major cause of 
morbidity and mortality worldwide (Purohit et al., 2009). Consequently, ethanol was used 
as a liver damaging agent in some experiments (Noh et al., 2011; Sathaye et al., 2010). 
Natural toxins such as aflatoxins are known to have toxic effect on liver. Aflatoxin B1, under 
the influence of microsomal cytochrome p-450 mediated oxidation, is biotransformed into 
aflatoxin 8-9-epoxide, which is a reactive intermediate and highly toxic (Iyer et al., 1994). 
The use of aflatoxin B1 and other aflatoxins as hepatotoxic agent in experimental animal was 
reported (Banu et al., 2009; Naaz et al., 2007). Chemicals such as trichloroacetic acid (Celik et 
al., 2009), nitrobenzene (Rathi et al, 2010), thioacetamide (Khatri et al, 2009) and heavy 
metals such as Cadmium (Obioha et al., 2009) were also utilized to induce experimental liver 
injury.  
Away from the use of chemicals, the hepatoprotective effect of some plant extracts was 
challenged against liver fibrosis caused by bile duct ligation (Fursule & Patil, 2010). 
4. Assement of hepatoprotective activity 
The experimental animals are usually treated with the plant extract under investigation for 
specified period of time. The hepatotoxic agent is usually administered near the end of the 
experimental period for induction of acute toxicity or in several doses during the course of 
the experiment for chronic toxicity. The hepatoprotective power of the tested material is 
assessed by measuring certain biochemical parameters, liver tissue parameters and 
comparing their levels with normal animals, group receiving standard drug in addition to 
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the hepatotoxic agent and group receiving only hepatotoxic agent. The most common 
measured parameters are summarized below. 
4.1 Serum biochemical parameters  
4.1.1 Transaminases  
Alanine transaminase (ALT), also called Serum Glutamic Pyruvate Transaminase (SGPT) or 
Alanine aminotransferase (ALAT) is an enzyme present in hepatocytes. Upon cell damaged, 
the enzyme leaks into the blood. SGPT level rises dramatically in acute liver damage, such 
as viral hepatitis or paracetamol overdose (Zimmerman & Seeff, 1970). Elevations are often 
measured in multiples of the upper limit of normal values. Aspartate transaminase (AST) 
also called Serum Glutamic Oxaloacetic Transaminase (SGOT) or aspartate aminotransferase 
(ASAT) is another enzyme associated with liver parenchymal cells. The level of SGOT is 
raised in acute liver damage, however, it is not specific as it is also present in red blood cells, 
heart, kidney and skeletal muscle. The ratio of SGOT to SGPT  is sometimes useful in 
differentiating between liver damage and other conditions that elevate the levels of 
transaminases (Nyblom et al., 2004; Feild et al., 2008). Effective hepatoprotective agents 
must decrease the elevated levels of transaminases and bring them closer to the normal 
values as a signe for liver healing. 
4.1.2 Alkaline phosphatase 
Alkaline phosphatase (ALP) catalysis the hydrolysis of phosphate esters, and is found in 
biliary epithelium and the bile canalicular region of hepatocytes. Its function is not well 
established, but is thought to involve in metabolite transport across cell membranes. 
Elevation of the level of ALP can suggest intrahepatic, extrahepatic biliary obstruction, or 
infiltrative diseases of the liver (Feild et al., 2008). Agents that can lower ALP levels will be 
considered as useful hepatoprotective agents. 
4.1.3 Bilirubin 
Bilirubin (Bil) is the breakdown product of normal haem -a part of haemoglobin in red 
blood cells- catabolism of aged erythrocytes. Bilirubin, loosely bound to albumin in plasma 
to form a soluble species taken up from the Disse spaces of liver sinusoids into hepatocytes, 
where it is esterified at its propionyl sites with glucuronic acid under the catalytic activity of 
uridinediphosphoglucuronate 1A1 transferase enzymes. Esterified bilirubin is excreted into 
bile as water-soluble bilirubin diglucuronide. Serum concentration of bilirubin is a marker 
of the liver’s ability to take up bilirubin from the plasma into the hepatocyte, conjugate it 
with glucuronic acid, and excrete bilirubin glucuronides into bile. Elevated level of serum 
conjugated bilirubin implies regurgitation of bilirubin glucuronides from hepatocytes back 
into plasma, usually because of intrahepatic or extrahepatic obstruction to bile outflow and 
cholestasis. The liver has substantial reserve capacity, and normal serum bilirubin levels can 
be maintained until there is enough injury to reduce the liver’s capacity to clear bilirubin 
from plasma. Serum concentration of bilirubin is very specific for potentially serious liver 
damage, and is an important indicator of the loss of liver function (Feild et al., 2008). 
Reduction in the level of serum bilirubin is a strong indication of restoring normal liver 
function.  
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4.1.4 Gamma glutamyl transpeptidase (GGT) 
Serum Gamma glutamyl transpeptidase (GGT) (also Gamma-glutamyl transferase) is 
specific to liver injury and more sensitive marker for cholestatic damage than ALP. GGT 
may be elevated with even minor, sub-clinical levels of liver dysfunction. GGT is raised in 
alcohol toxicity following several days of moderate ingestion. Rifampin, phenytoin, or 
barbiturates all resulted in elevation of GGT level. An isolated GGT elevation in these 
situations does not indicate hepatocellular injury. The GGT level will return to normal after 
discontinuation of the offending agent. Hepatic dysfunction should be considered if the 
GGT elevation is associated with other abnormalities in liver biochemistry (Owvens& 
Evans, 1975). Hepatoprotective agents will reduce the elevated level of GGT. 
4.1.5 Total protein & albumin (Alb) 
One of the most important liver functions is protein synthesis. Albumin is a major part of 
the total protein (TP) made specifically by the liver. Liver damage causes disruption and 
disassociation of polyribosomes on endoplasmic reticulum and thereby reducing the 
biosynthesis of protein. The TP levels including Alb levels will be depressed in hepatotoxic 
conditions due to defective protein biosynthesis in liver. Restoring the normal levels of TP 
including Alb is an important parameter for liver recovery (Navarro & Senior, 2006). 
4.2 Liver tissue parameters  
4.2.1 Glutathione and antioxidant enzymes 
Glutathione (GSH) and its related enzymes are playing a vital role as intracellular 
antioxidants. GSH prevents damage to important cellular components caused by reactive 
oxygen species such as free radicals and peroxides (Pompella et al., 2003). Glutathione exists 
in both reduced (GSH) and oxidized (GSSG) states as well. In the reduced state, the thiol 
group of cysteine is able to donate a reducing equivalent (H++ e-) to other unstable 
molecules, such as ROS. In donating an electron, GSH itself becomes reactive, but readily 
reacts with another reactive GSH to form glutathione disulfide (GSSG). Such a reaction is 
possible due to the relatively high concentration of glutathione in cells (up to 5 mM in the 
liver). GSH can be regenerated from GSSG by the enzyme glutathione reductase (GSR or 
GR) (Boyer, 1989; Tandogan & Ulusu, 2006). In healthy cells and tissues, more than 90% of 
the total glutathione pool is in the reduced form (GSH) and less than 10% exists in the 
disulfide form (GSSG). An increased GSSG-to-GSH ratio is considered indicative of 
oxidative stress (Pastore et al., 2003). Another protection from oxidative damage is assured 
by Glutathione peroxidase (GPx), an enzyme family with peroxidase activity. GPx reduce 
lipid hydroperoxides to their corresponding alcohols and breakdown hydrogen peroxide 
into water and oxygen (Castro & Freeman, 2001). 
The glutathione S-transferase (GSTs) family are composed of many cytosolic, mitochondrial, 
and microsomal proteins. GSTs catalyze a variety of reactions and accept endogenous and 
xenobiotic substrates as well (Udomsinprasert et al., 2005). GSTs catalyse the conjugation of 
reduced glutathione - via a sulfhydryl group - to electrophilic centres on a wide variety of 
substrates (Douglas, 1987). This activity detoxifies endogenous compounds such as 
peroxidised lipids, and enable the breakdown of xenobiotics. GSTs may also bind toxins and 
serve as transport proteins (Leaver & George, 1998). 
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Plant Dose 
SGOT SGPT ALP T.Bil 
Ref. 
Test St Test St Test St Test St 
Abutilon indicum 200  64.6 81.5 69.2 90.5 46.9 62.7 54.6 73.8 Porchezhian & Ansari, 2005 
Abutilon indicum a 200  32.7 68.5 78.8 83.8 52.3 72.4 60.7 70.8 Porchezhian & Ansari, 2005 
Adhatoda vasica 100 53.3 62.8 56.0 59.4 - - - - Bhattacharyya et al., 2005 
Anisochilus carnosus 400 52.8 54.9 29.9 30.1 28.2 28.7 13.2 10.5 Venkatesh et al., 2011 
Arachniodes exilis 750 71.9 75.8 41.7 49.3 - - - - Zhou et al., 2010 
Artemisia absinthium 200 64.7 70.9 60.1 61.4 - - - - Amat et al., 2010 
Azadirachta indica a 500 30.6 36.4 26.9 59.0 28.0 45.5 40.4 53.6 Gomase et al., 2011 
Balanites aegyptiaca 500 28.7 56.9 29.9 64.5 21.5 42.8 38.4 52.0 Abdel-Kader & Alqasoumi, 2008 
Bixa orellana 500 57.37 - 52.08 - - - 21.15 - Ahsan et al., 2009 
Butea monosperma 800 52.1 53.2 78.1 87.1 - - - - Sharma & Shukla, 2010 
Byrsocarpus coccineus* 400 44.3 42.9 68.4 55.9 49.0 38.5 46.6 51.0 Akindele et al., 2010 
Cajanus cajan 500 56.53 - 50.22 - - - 25.0 - Akindele et al., 2010 
Calotropis procera a 400 62.2 66.5 69.1 73.5 58.4 61.9 68.7 69.6 Setty et al., 2007 
Cassia fistula a, ** 400 54.0 64.3 46.4 63.1 53.9 58.2 54.1 66.5 Bhakta et al., 2001 
Castanea crenata c 150 54.1 - 70.6 - - - - - Noh et al., 2011 
Carduus nutans 500 44.16 - 64.68 - - - - - Aktay et al., 2000 
Chamomile capitula a 400 - - - - 82.6  74.2 - Gupta & Misra, 2006 
Cichorium intybus 500 81.9 78.1 56.1 84.3 40.8 47.3 - - Ahmed et al., 2003 
Cistanche tubulosa 1000 91.6 - 89.7 - - - - - Morikawa et al., 2010 
Clerodendrum inerme 200 31.6 40.1 83.0 85.6 88.4 89.0 - - Gopal & Sengottuvelu, 2008 
Commiphora berryi 200 45.6 44.4 65.8 62.4 61.1 65.7 56.3 73.6 Shankar et al., 2008 
C. opobalsamum 500 66.2 - 75.6 - 33.0 - 37.3 - Al-Howiriny et al., 2004 
Coptidis rhizoma 600 93.9 - 82.5 - - - - - Ye et al., 2009 
Cordia macleodii 200 84.8 86.5 77.5 82.2 63.3 60.6 40.6 42.2 Qureshi et al., 2009 
Cuscuta chinensis a 250 86.8 - 81.6 - 31.0 - - - Yen et al., 2007 
Enicostemma axillare b 200 91.1 92.2 45.3 20.4 49.2 40.3 33.3 18.6 Jaishree & Badami, 2010 
Ephedra foliata 500 42.6 55.1 39.5 66.1 21.2 39.6 46.2 63.5 Alqasoumi et al., 2008b 
Euphorbia fusiformis 500 43.1 43.7 30.2 31.7 34.7 37.1 99.9 65.9 Anusuya et al., 2010 
Ficus glomerata 500 44.0 30.4 72.8 57.2 68.5 74.6 - - Channabasavaraj et al., 2008 
Filipendula ulmaria 100 58.7 - 81.9 - - - - - Shilova et al., 2008 
Fumaria indica b 400 72.6 - 79.0 - 68.2 - 79.7 - Rathi et al., 2008 
F. vailantii 500 60.75 - 66.93 - - - - - Aktay et al., 2000 
Ganoderma lucidum b 180 76.6 - 83.6 - - - - - Shi et al., 2008 
Gentiana olivieri 500 69.57 - 86.39 - - - - - Aktay et al., 2000 
Hibiscus sabdariffa 500 44.5 66.5 37.1 65.02 21.0 50.6 35.0 69.6 Alqasoumi et al., 2008b 
Halenia elliptica 200 57.2 48.8 58.0 47.6 39.0 49.4 46.6 48.6 Huang et al., 2010b 
Hedyotis corymbosa a 200 59.6 60.8 75.8 66.9 81.0 79.2 37.8 72.4 Sadasivan et al., 2006 
Helminthostachys zeylanica 300 64.3 65.0 77.7 78.2 44.3 45.1 66.4 74.0 Suja et al., 2004 
Hygrophila auriculata 150 40.8 43.2 24.9 23.5 28.1 26.2 53.0 60.2 
Shanmugasundara & Venkataraman, 
2006 
Kyllinga nemoralis 200 45.6 42.5 68.3 65.5 61.3 66.0 46.6 51.1 Somasundaram et al., 2010 
Laggera pterodonta 100 39.6 7.3 31.3 12.5 - - - - Wu et al., 2007 
Laggera pterodonta b,*** 100 41.9 9.3 35.0 7.5 - - - - Wu et al., 2007 
Mollugo pentaphylla 200 37.2 43.6 53.0 63.9 55.1 55.6 32.6 36.0 Valarmathi et al., 2010 
Momordica balsamina 500 37.5 57.6 39.1 57.1 23.2 37.5 52.7 62.0 Alqasoumi et al., 2009b 
M. dioica 200 44.7 64.0 54.3 54.6 51.9 59.7 31.1 58.5 Jain et al., 2008 
Nelumbo nucifera 500 82.8 82.0 76.5 74.3 39.7 42.0 46.5 50.5 Huang et al., 2010a 
Phyllanthus amarus d 75 16.6 21.9 28.1 31.8 - - - - Pramyothin, et al., 2007 
Pittosporum neelgherrense   200 70.6 71.9 54.1 55.5 - - - - Shyamal et al., 2006 
Pittosporum neelgherrenseb 200 65.5 65.4 58.4 59.1 - - - - Shyamal et al., 2006 
Propolis 500 29.4 53.4 37.3 60.2 25.5 43.5 30.1 57.0 Alqasoumi et al., 2008a 
Premna corymbosa 400 - - - - 61.6 52.4 - - Karthikeyan & Deepa, 2010 
Rubus aleaefolius 35 12.7 - - - - - - - Hong et al., 2010 
Sida acuta a 100 61.9 60.7 67.7 66.9 79.6 79.2 67.3 72.4 Sreedevi et al., 2009 
Smilax regelii 500 13.5 - 47.0 - - - 56.4 - Rafatullah et al., 1991  
 
 
 
a Paracetamol, b D-galactosamine, c ethanol, d aflatoxin, e nitrobenzene, f thioacetamide- induced liver 
toxicity, otherwise CCl4 was used  
* Livolin, ** Liver tonic, *** Silibinin were used as hepatoprotective standard, otherwise silymarin was use 
Table 1. Effect of selected plants on serum biochemical parameters 
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Treatment of animals with hepatotoxic agents lead to depletion of GSH, reduction in the 
non-protein sulfhydryl moiety (NP-SH), GPx, GSR activities and ultration of GSTs activity 
(Naaz et al., 2007; Mitchell et al., 1973; Abdel-Kader et al., 2010; Alqasoumi et al., 2009).  
Another part of the antioxidant systems in the bodies is the enzymes Superoxide dismutases 
(SOD) and Catalase (CAT) (Scott et al., 1991). They are an important antioxidant defence 
containing heavy metals in nearly all cells exposed to oxygen. SOD catalyzes the 
dismutation of superoxide into oxygen and hydrogen peroxide. SOD is the most efficient 
catalytic enzyme; its activity is only limited by the frequency of collision between itself and 
superoxide (Fredovich, 1997). 
CAT catalyzes the decomposition of hydrogen peroxide to water and oxygen (Chelikani et 
al., 2004). CAT has one of the highest turnover numbers of all enzymes; one CAT enzyme 
can convert 40 million molecules of hydrogen peroxide to water and oxygen per second 
(RCSB Protein Data Bank, 2007). 
Effective hepatoprotactive agents will be able to restore the normal levels of these systems in 
liver tissue. 
4.2.2 Harmful peroxidation products 
Malonaldehyde (MDA) is the main end-product of polyunsaturated fatty acid peroxidation 
(PUFA) following Reactive oxygen species (ROS) insult (Esterbauer et al., 1991). PUFA are 
essential part of biological membranes (Vaca et al., 1988). MDA is a reactive aldehyde and is 
one of many reactive electrophile species that cause toxic stress in cells and form covalent 
protein adducts (Farmer & Davoine, 2007). The production of this aldehyde is used as a 
biomarker to measure the level of oxidative stress in an organism (Del Rio et al., 2005). The 
increase in liver MDA levels induced by hepatotoxic agents suggests enhanced lipid 
peroxidation, leading to hepatic tissue damage and failure of endogenous antioxidant 
defence mechanisms to prevent formation of excessive free radicals (Souza et al., 1997).  
ThioBarbituric Acid Reactive Substances (TBARS) are another harmful substances formed 
by lipid peroxidation. TBARS are one of the end products formed during the decomposition 
of lipids by ROS (Olinescu et al., 1994). The tissue concentration of TBARS increase with 
induced liver toxicity (Sabir & Rocha, 2008). 
Physiological amounts of nitric oxide (NO) in the liver has protective effect against damage 
induced by tumour necrosis factor-a or Fas-dependent apoptosis (Fiorucci et al., 2001). The 
production of high levels of NO within the liver, via inducible NO synthase (iNOS) promote 
damage via interference with mitochondrial respiration (Moncada & Erusalimsky, 2002). 
Hepatocytes of experimental animals produce NO during chronic hepatic inflammation 
(Billiar et al., 1990 a, b). Human hepatocytes were also stimulated to produce NO by the 
same combination of endotoxin and cytokines as rat hepatocytes (Palmer et al., 1988; 
Nussler et al., 1992).  
ROS are known to convert amino groups of protein to carbonyl moieties (Perry et al. 2000). 
Oxidative modification of protein leads to increased recognition and degradation by 
proteases and loss of enzymatic activity (Rivett & Levine, 1990). Accumulation of carbonyl 
derivatives of proteins (protein carbonyl) is taken as a biomarker of oxidative protein 
damage in aging and in various diseases (Dalle-Donne et al., 2003). 
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Plant 
Dose SOD CAT GSH GPx MDA TBARS 
            
Abutilon indicum 200  - - - - 81.4 82.8 - - - - - 
Abutilon indicum a 200 - - - - 75.9 77.3 - - - - - 
Adhatoda vasica 100 - - - - - - - - - - 55.4 55.7
Arachniodes exilis 750 88.4 91.4 - - - - - - 50.0 55.4 - 
Artemisia absinthium 200 88.0 90.1 - - - - 71.7 89.0 54.9 58.6 - 
Butea monosperma 800 - - - - 92.3 92.3 - - - - - 
Byrsocarpus coccineus * 400 92.8 73.6 93.7 73.6 104.5 75.5 92.2 96.0 82.7 87.3 - 
Calotropis procera a 400 - - - - 58.4 60.5 - - - - - 
Castanea crenata c 150 104.8 - 89.0 - - - 38.6 - - - 21.8 
Carduus nutans 500 - - - - - - - - 34.8 - - 
Chamomile capitula a 400 - - - - 91.0 - - - - - 50.2 
Clerodendrum inerme 200 - - - - 92.9 88.2 - - - - - 
C. opobalsamum 500 - - - - 92.6 - - - - - - 
Coptidis rhizoma 600 97.5 - - - - - - - - - - 
Cuscuta chinensis a 250 87.4 - 86.6 - - - 95.6 - 55.4 - - 
Ficus glomerata 500 62.5 106.3 105.0 101.7 - - - - - - 44.1 45.7
Filipendula ulmaria 100 66.0 56.1 92.9 73.2 - - - - - - 48.4 35.2
Fumaria indica b 400 - - - - - - 89.8 93.2 48.6 55.1 - 
F. vailantii 500 - - - - - - - - 33.7 - - 
Ganoderma lucidum b 180 98.5 - - - 96.1 - - - 51.6 - - 
Gentiana olivieri 500 - - - - - - - - 32.3 - - 
Kyllinga nemoralis 200 66.1 51.4 81.3 87.3 59.0 57.2 - - 51.1 52.6 - 
Memordica  dioica 200 76.8 84.5 83.0 91.5 85.3 88.0 - - 36.0 48.8 - 
Nelumbo nucifera 500 85.4 76.5 87.9 55.7 126.0 78.7 - - - - 31.0 31.7
Phyllanthus amarus d 75 85.4 - 100.1 - 202.3 - 108.0 - - - 48.3 
Rubus aleaefolius 35 89.8 - - - - - - - 20.1 - - 
Tecomella undulata e 1000 - - - - 134.9 150.9 - - 50.7 69.4 - 
Tephrosia purpurea e 500 - - - - 139.0 150.9 - - 65.0 69.4 - 
Trichosanthes cucumerina 500 - - - - 93.8 94.9 - - 51.2 54.4 - 
Spermacoce hispida 200 85.1 - 82.9 - - - 89.9 - 51.7 - - 
Uvaria chamae a 60 - - - - - - - - - - - 
Zanthoxylum armatum 400 93.7 99.7 90.9 97.9 89.0 94.2 - - 67.3 70.0 - 
a Paracetamol, b D-galactosamine, c ethanol, d aflatoxin, e thioacetamide- induced liver toxicity, otherwise CCl4 wa
* Livolin was used as hepatoprotective standard, otherwise silymarin was use 
Table 2. Effect of selected plants on liver tissue parameters 
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4.3 Barbiturates sleep time 
Short acting barbiturates such as hexobarbiton are metabolized almost exclusively in the 
liver. Duration of barbiturates induced sleep in intact animals is considered as a reliable 
index for the activity of hepatic metabolism (Vogel, 1977). Pre-existing liver damage will 
result in prolongation of the sleeping time after a given dose of barbiturates due to decrease 
in the amount of the hypnotic broken down per unit time as a result of decreased 
availability of CYP2E1 contents (Singh et al., 2001). Extracts that can shorten this 
prolongation of barbiturates sleep time exert protective effect on CYP2E1 system. 
4.4 Histopathological study of liver tissue 
The histological appearance of the hepatocytes reflects their damage conditions (Prophet, et 
al., 1994). Exposure of hepatocytes to toxic agents such as carbon tetrachloride leads to 
histopathological changes from the normal histological appearance (Fig. 1). The hepatocytes 
of rat treated with carbon tetrachloride, showed centrilobular necrosis and extensive fatty 
changes observed on the midzonal or entire lobe 24 h after treatment (Fig. 1B). Liver tissues 
of rats treated with carbon tetrachloride and the standard drugs like silymarin showed no 
necrosis or fatty deposition but had only minimal portal inflammation (Fig.1C). The 
protective effect of tested extracts or pure materials will be expressed in histopathology as 
the ability to improve the histological appearance of hepatocytes and bring it closer to the 
normal hepatocytes of healthy liver (Fig.1A).  
 
1A 1B 1C  
Fig. 1. Histological appearance of normal liver (1A), rat liver treated with carbon 
tetrachloride (1B), rat liver treated with silymarin+ carbon tetrachloride (1C)(H & E, 200). 
5. Literature results for some promising hepatoprotective plants  
Many plant extracts were tested for their hepatoprotective activity against various liver 
toxins. All the above mentioned parameters were used to evaluate the protective power of 
such plants against liver cells damage. In the following Tables some of the most promising 
results are presented. For handy comparative evaluation of the results percentage of 
protection is presented even if it was not calculate in the original article. For values where 
normal levels are increase due to destruction of hepatocytes integrity ( SGOT, SGEPT) or 
over production of harmful oxidation products (MDA, TBARS) calculations were preformed 
based on control groups receiving the hepatotoxic agents. Percentage of reduction in the 
elevated values was compared to protection achieved by silymarin or any other 
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hepatoprotective agents used in the original articles. On the other hand when experimental 
liver toxicity resulted in decrease in the normal levels of the measured parameters like the 
case of normal protective antioxidant enzymes (SOD, CAT), the protection efficacy is 
presented as percent recovery relative to the negative control values.  
6. Summary, conclusions and future directions 
Liver diseases represent a major global health problem that still has no cure in modern 
medicine. Some of the traditionally used plants for liver disorders provided useful 
therapeutic agents. A large number of such plants lack the scientific evidences supporting 
their effectiveness. Many groups of researchers worldwide were involved in studying the 
protective effects of plant extracts against experimentally induced liver toxicity. Rats and 
mice are the animals of choice in such experiments. Carbon tetrachloride followed by 
paracetamol and D-galactosamine (D-GalN) were used to induce liver toxicity in addition to 
ethanol and some other drugs affecting the liver on prolonged use. In most cases, positive 
control groups received silymarin as standard drug for liver protection. Both serum 
biochemical parameters, liver tissue parameters, barbiturates sleeping time and 
histopathological examination were used to access liver protection. The most promising data 
were presented in tables 1 and 2. These biological studies are extremely important to 
discriminate between useful and useless plants claimed to have liver healing properties. 
Scientific examination of all traditionally used plants for liver problems is a great goal still to 
be achieved. This collection of data can be a helpful guide for Phytochemists to explore the 
constituents of the most promising plants in order to discover new useful natural drugs for 
the management of liver disorders.  
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